Epidemiology of acute promyelocytic leukemia in Italy. APL Collaborating Group. 1991

G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
Dipartimento di Biopatologia Umana, Università La Sapienza, Italy.

This retrospective epidemiologic study on 256 cases of Acute Promyelocytic Leukemia (APL) observed in 20 Italian hematology centers between 1980 and 1988 demonstrated that APL is different from the other acute non-lymphocytic leukemias (ANLL). The male/female ratio was 0.9; median age at diagnosis was 40 years (with 80% of patients between 15 and 54 years of age). The minimal annual incidence of APL in Italy per 1,000,000 inhabitants was estimated to be 0.6; an increased incidence was observed in spring and in autumn. The overall median survival duration of APL patients was 12.6 months. From an epidemiological point of view APL is a distinctive subtype of ANLL.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015473 Leukemia, Promyelocytic, Acute An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. Leukemia, Myeloid, Acute, M3,Leukemia, Progranulocytic,Myeloid Leukemia, Acute, M3,Progranulocytic Leukemia,Promyelocytic Leukemia, Acute,AML M3,Acute Promyelocytic Leukemia,Leukemia, Acute Promyelocytic,M3 ANLL,ANLL, M3,Acute Promyelocytic Leukemias
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
November 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
January 2019, [Rinsho ketsueki] The Japanese journal of clinical hematology,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
February 1979, Cancer,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
August 2003, Leukemia,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
April 2004, Leukemia,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
February 1983, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
January 1991, Nouvelle revue francaise d'hematologie,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
March 2020, Oncotarget,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
January 1998, Medical and pediatric oncology,
G Avvisati, and A Mele, and M A Stazi, and M L Vegna, and P Pasquini, and F Mandelli
January 2014, Mediterranean journal of hematology and infectious diseases,
Copied contents to your clipboard!